BRAF and melanoma: This protein kinase is involved in RAS–RAF–MEK–ERK mitogen-activated protein kinase signaling.1 Among the BRAF mutations, the V600E gain-of-function substitution is most commonly observed (i.e. in 40–60% of all melanomas).